Recent findings from an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65 and 80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study was published in the Journal of the American Medical Association. Thanks to better cancer prevention education and the resulting wide-spread increase in using prostate-specific antigen (PSA) screenings, more men are being diagnosed with early-stage and low-or intermediate-grade prostate cancer. Studies have shown that the slow-developing nature of prostate cancer during its earliest stages makes treatment options, such as a radical prost...

Fresh data on prostate cancer are presented in the report "Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Green tea and its major constituent epigallocatechin gallate (EGCG) have been extensively studied as a potential treatment for a variety of diseases, including cancer. Epidemiological data have suggested that EGCG may provide protective effects against hormone related cancers, namely breast or prostate cancer," scientists in Dunedin, New Zealand report. "Extensive in vitro investigations using both hormone responsive and non-responsive cell lines have shown that EGCG induces apoptosis and alters the expression of cell cycle regulatory proteins that are critical for cell survival and apoptosis....

Being diagnosed with prostate cancer nowadays is by no means a death sentence however it is imperative that you get treatment without delay. There are a number of prostate cancer treatment options ava

Being diagnosed with prostate cancer is a big shock for anyone however you should not immediately write your life off as there are a number of very successful prostate cancer treatments now available.

Title: Weight Loss May Cut Prostate Cancer Risk
Category: Health News
Created: 12/23/2006 2:06:00 AM
Last Editorial Review: 12/26/2006

Is a prostate cancer screening test doing more harm than good? Dr. Dean Edell reports on the possibility of over-diagnosis.

The results of the study are actually quite simple: lose weight and your chances of developing the most aggressive forms of the disease may go down by about 40%.